Cellectis S.A. Shares 2011-2026 | CLLS

Annual Shares Cellectis S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	44.8 M	42.5 M	45.8 M	45.8 M	37.3 M	35.3 M	34.1 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
45.8 M	34.1 M	40.8 M

Quarterly Shares Cellectis S.A.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	45.5 M	-	-	-	42.5 M	-	-	-	42.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
45.5 M	42.4 M	43.5 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
Biogen BIIB	146 M	$ 173.17	0.92 %	$ 25.2 B	USA
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Adagene ADAG	56.3 M	$ 2.4	-3.61 %	$ 135 M	China
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
BioNTech SE BNTX	244 M	$ 117.62	1.41 %	$ 27.2 B	Germany
Aptorum Group Limited APM	5.45 M	$ 0.98	1.35 %	$ 5.34 M	China
Alterity Therapeutics Limited ATHE	2.41 B	$ 3.67	3.38 %	$ 8.83 B	Australia
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Catalyst Biosciences CBIO	65.8 M	$ 11.66	-8.95 %	$ 768 M	USA
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
BioXcel Therapeutics BTAI	2.54 M	$ 1.77	-2.75 %	$ 4.49 M	USA
BioLineRx Ltd. BLRX	663 M	$ 3.12	0.59 %	$ 908 M	Israel
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Ascendis Pharma A/S ASND	54.8 M	$ 233.49	-0.81 %	$ 5 B	Danmark
Burford Capital Limited BUR	219 M	$ 9.71	-0.46 %	$ 1.57 B	Britain
ARCA biopharma ABIO	16.8 M	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	12.1 M	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	134 M	$ 67.41	0.54 %	$ 9.02 B	USA
Compugen Ltd. CGEN	89.5 M	$ 2.04	-2.39 %	$ 183 M	Israel
Can-Fite BioPharma Ltd. CANF	2.18 B	$ 4.36	-2.46 %	$ 9.49 B	Israel
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.08 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	60.3 M	-	-	$ 1.01 B	USA
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Adaptimmune Therapeutics plc ADAP	1.21 B	-	-15.15 %	$ 60.3 M	Britain
Amphastar Pharmaceuticals AMPH	48.4 M	$ 26.57	2.51 %	$ 1.29 B	USA
Coherus BioSciences CHRS	94.2 M	$ 2.26	9.7 %	$ 213 M	USA
Amneal Pharmaceuticals AMRX	309 M	$ 13.59	1.46 %	$ 4.2 B	USA
AIkido Pharma AIKI	6.18 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	19.2 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Aptose Biosciences APTO	699 K	-	-45.71 %	$ 1.2 M	Canada
Acer Therapeutics ACER	15.8 M	-	2.71 %	$ 14 M	USA
Aravive ARAV	36.4 M	-	-13.39 %	$ 1.45 M	USA
Alpine Immune Sciences ALPN	33.4 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.01 M	-	4.14 %	$ 49.1 M	USA
Athira Pharma ATHA	38.5 M	-	-	$ 269 M	USA
Ampio Pharmaceuticals AMPE	810 K	-	-11.43 %	$ 502 K	USA
Celldex Therapeutics CLDX	64.4 K	$ 26.72	3.09 %	$ 1.72 M	USA
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	6.28 M	$ 2.75	1.85 %	$ 17.3 M	USA
AstraZeneca PLC AZN	1.42 B	$ 94.24	1.38 %	$ 96.9 B	Britain
Arena Pharmaceuticals ARNA	60.8 M	-	-6.81 %	$ 3.04 B	USA
Brickell Biotech BBI	5.39 M	-	-5.38 %	$ 6.06 M	USA